Filing Details
- Accession Number:
- 0000899243-23-007334
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-07 16:05:43
- Reporting Period:
- 2023-03-06
- Accepted Time:
- 2023-03-07 16:05:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1704292 | Zai Lab Ltd | ZLAB | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1835780 | Iii Titus Frazor Edmondson | C/O Zai Lab Limited 314 Main Street, 4Th Floor, Suite 100 Cambridge MA 02142 | Chief Legal Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| American Depositary Shares | Disposition | 2023-03-06 | 7,965 | $40.55 | 19,400 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. The issuer's ADSs and Ordinary Shares are fully fungible, and this Form 4 reports transactions in terms of ADSs.
- The reported transaction was effected pursuant to a sale plan adopted by the Reporting Person, dated 11/14/2022, that expires on 11/30/2023 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
Billionaire Hedge Funds
